Average Co-Inventor Count = 3.35
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Biotech, Inc. (24 from 410 patents)
2. Centocor Ortho Biotech Inc. (6 from 31 patents)
3. Centocor, Inc. (5 from 144 patents)
4. Other (2 from 832,880 patents)
5. Bristol-myers Squibb Compnay (1 from 3,685 patents)
6. Centoco Ortho Biotech Inc. (1 from 1 patent)
39 patents:
1. 12304939 - EGFR and C-met fibronectin type III domain binding molecules
2. 12291797 - Fibronectin type III domain based scaffold compositions, methods and uses
3. 12054534 - Prostate specific membrane antigen binding fibronectin type iii domains
4. 11833190 - Serum albumin-binding fibronectin type III domains
5. 11702475 - Cysteine engineered fibronectin type III domain binding molecules
6. 11479880 - Fibronectin type III domain based scaffold compositions, methods and uses
7. 11072663 - Cysteine engineered fibronectin type III domain binding molecules
8. 10954284 - EGFR and c-Met fibronectin type III domain binding molecules
9. 10925932 - Serum albumin-binding fibronectin type III domains
10. 10844122 - Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof
11. 10844111 - Prostate specific membrane antigen binding fibronectin type III domains
12. 10662235 - Cysteine engineered fibronectin type III domain binding molecules
13. 10654913 - Fibronectin type III domain based scaffold compositions, methods and uses
14. 10196446 - Cysteine engineered fibronectin type III domain binding molecules
15. 10040842 - Fibronectin type III domain based scaffold compositions, methods and uses